why do some people not lose weight on glp 1 Jennifer Manne-Goehler, MD, ScD, explains GLP-1 medications shouldn't be used as a "quick fix" and outlines what to consider before taking them GLP-1 Medications Infographic | Medidex

Failure to identify the responsible drug can lead to significant delays in treatment, potentially resulting in critical outcomes (Jones et al., 2015)

For instance, liraglutide (Victoza), dulaglutide (Trulicity), and subcutaneous semaglutide (Ozempic) have data supporting risk reduction of major adverse cardiovascular events as well as preserving kidney function in patients with T2DM.(2)(3)(4) Another benefit of GLP-1 and GIP/GLP-1 receptor agonists is significant weight loss, specifically seen with liraglutide, semaglutide, and tirzepatide, which are now available as FDA approved products for weight management with the brand names Saxenda, Wegovy, and Zepbond respectively.(5)(6)(7) While these products have great glycemic, weight, and cardiovascular outcomes, the benefits have resulted in some detrimental repercussions

Injectable dose: 200 to 500 mcg/day subcutaneous for widespread conditions

Peptide stacking works because individual compounds target different biological pathways

These products may be counterfeit, contaminated, improperly stored, incorrectly dosed, or contain inactive or harmful ingredients